- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/454 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Patent holdings for IPC class A61K 31/454
Total number of patents in this class: 5475
10-year publication summary
|
411
|
425
|
445
|
449
|
467
|
501
|
529
|
495
|
413
|
95
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Corporation | 1412 |
161 |
| Novartis AG | 11238 |
90 |
| Takeda Pharmaceutical Company Limited | 2961 |
87 |
| Bristol-myers Squibb Company | 5080 |
78 |
| Janssen Pharmaceutica N.V. | 3839 |
74 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
60 |
| Abbvie Inc. | 1808 |
53 |
| Merck Sharp & Dohme LLC | 3689 |
48 |
| Boehringer Ingelheim International GmbH | 4629 |
47 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
45 |
| F. Hoffmann-La Roche AG | 7958 |
43 |
| Vanda Pharmaceuticals, Inc. | 336 |
41 |
| Pfizer Inc. | 3322 |
39 |
| AstraZeneca AB | 3042 |
38 |
| Toray Industries, Inc. | 6652 |
38 |
| The Children's Hospital of Philadelphia | 716 |
36 |
| Immunomedics, Inc. | 290 |
36 |
| Shionogi & Co., Ltd. | 914 |
36 |
| The Regents of the University of California | 18943 |
34 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
34 |
| Other owners | 4357 |